NO982202D0 - Eksitatoriske aminosyrederivater - Google Patents
Eksitatoriske aminosyrederivaterInfo
- Publication number
- NO982202D0 NO982202D0 NO982202A NO982202A NO982202D0 NO 982202 D0 NO982202 D0 NO 982202D0 NO 982202 A NO982202 A NO 982202A NO 982202 A NO982202 A NO 982202A NO 982202 D0 NO982202 D0 NO 982202D0
- Authority
- NO
- Norway
- Prior art keywords
- amino acid
- acid derivatives
- excitatory amino
- excitatory
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US686495P | 1995-11-16 | 1995-11-16 | |
GBGB9605434.1A GB9605434D0 (en) | 1996-03-15 | 1996-03-15 | Excitatory amino acid derivatives |
PCT/US1996/018112 WO1997018199A1 (en) | 1995-11-16 | 1996-11-12 | Excitatory amino acid derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
NO982202L NO982202L (no) | 1998-05-14 |
NO982202D0 true NO982202D0 (no) | 1998-05-14 |
Family
ID=26308935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO982202A NO982202D0 (no) | 1995-11-16 | 1998-05-14 | Eksitatoriske aminosyrederivater |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0774461B1 (no) |
KR (1) | KR19990067598A (no) |
CN (1) | CN1202167A (no) |
AR (2) | AR004602A1 (no) |
AT (1) | ATE319685T1 (no) |
AU (1) | AU703409B2 (no) |
BR (1) | BR9611511A (no) |
CA (1) | CA2237910C (no) |
CO (1) | CO4770955A1 (no) |
CZ (1) | CZ150198A3 (no) |
DE (1) | DE69635886T2 (no) |
EA (1) | EA001617B1 (no) |
ES (1) | ES2258771T3 (no) |
HU (1) | HUP9903459A3 (no) |
IL (1) | IL124487A (no) |
NO (1) | NO982202D0 (no) |
NZ (1) | NZ323205A (no) |
PE (1) | PE17798A1 (no) |
PL (1) | PL326695A1 (no) |
TR (1) | TR199800877T2 (no) |
WO (1) | WO1997018199A1 (no) |
YU (1) | YU60796A (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998032436A1 (en) * | 1997-01-29 | 1998-07-30 | Eli Lilly And Company | Treatment for premenstrual dysphoric disorder |
US6204292B1 (en) | 1997-07-18 | 2001-03-20 | Georgetown University | Bicyclic metabotropic glutamate receptor ligands |
US6825211B1 (en) | 1997-07-18 | 2004-11-30 | Georgetown University | Bicyclic metabotropic glutamate receptor ligands |
DE19801646A1 (de) | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte alpha,beta-annellierte Butyrolactone |
DE19801648A1 (de) * | 1998-01-17 | 1999-07-22 | Bayer Ag | alpha-Substituierte Lactone |
DE19801647A1 (de) * | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte beta,gamma-annellierte Lactone |
DE19801636A1 (de) * | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte bicyclische Lactone |
GB2355982A (en) * | 1999-11-03 | 2001-05-09 | Lilly Co Eli | Heterocyclic amino acids |
TW200833674A (en) * | 2002-06-11 | 2008-08-16 | Lilly Co Eli | Prodrugs of excitatory amino acids |
EP2370377B1 (en) | 2008-11-14 | 2015-09-16 | DSM Fine Chemicals Austria Nfg GmbH & Co KG | Process for the production of cyclopropane derivatives |
WO2010111080A2 (en) | 2009-03-27 | 2010-09-30 | Eli Lilly And Company | Optimized treatment of schizophrenia |
US8735397B2 (en) | 2010-03-29 | 2014-05-27 | Vanderbilt University | Method for treating schizophrenia and related diseases |
KR101598679B1 (ko) | 2011-06-17 | 2016-02-29 | 일라이 릴리 앤드 캄파니 | mGlu2 수용체 효능제로서의 비시클로(3.1.0)헥산-2,6-디카르복실산 유도체 |
AR089718A1 (es) | 2012-02-01 | 2014-09-10 | Lilly Co Eli | AGONISTAS DE mGlu2/3 |
CN106061504B (zh) * | 2014-01-21 | 2019-09-06 | 詹森药业有限公司 | 包括代谢型谷氨酸能受体亚型2的正别构调节物或正位激动剂的组合及其用途 |
KR20200126026A (ko) | 2014-01-21 | 2020-11-05 | 얀센 파마슈티카 엔.브이. | 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2572842A (en) * | 1947-08-05 | 1951-10-30 | Du Pont | The n-carboanhydride of 2-amino-4, 6, 6-trimethylheptanoic acid and polymers therefrom |
US4536330A (en) * | 1982-09-23 | 1985-08-20 | International Flavors & Fragrances Inc. | 1-Hydroxymethyl-2-acyl cyclopropane derivatives and esters and cyclic condensation products thereof, organoleptic uses of same and processes for preparing same |
PL182285B1 (pl) * | 1994-08-12 | 2001-12-31 | Lilly Co Eli | Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL |
AU3325095A (en) * | 1994-08-12 | 1996-03-07 | Eli Lilly And Company | Composition and method for protection against drug dependency |
PT776201E (pt) * | 1994-08-12 | 2002-03-28 | Lilly Co Eli | Composicao e metodo para tratar a ansiedade |
-
1996
- 1996-11-12 KR KR1019980703624A patent/KR19990067598A/ko not_active Application Discontinuation
- 1996-11-12 WO PCT/US1996/018112 patent/WO1997018199A1/en not_active Application Discontinuation
- 1996-11-12 CA CA002237910A patent/CA2237910C/en not_active Expired - Fee Related
- 1996-11-12 CN CN96198396A patent/CN1202167A/zh active Pending
- 1996-11-12 PL PL96326695A patent/PL326695A1/xx unknown
- 1996-11-12 BR BR9611511A patent/BR9611511A/pt active Search and Examination
- 1996-11-12 NZ NZ323205A patent/NZ323205A/xx unknown
- 1996-11-12 TR TR1998/00877T patent/TR199800877T2/xx unknown
- 1996-11-12 IL IL12448796A patent/IL124487A/xx not_active IP Right Cessation
- 1996-11-12 EA EA199800377A patent/EA001617B1/ru not_active IP Right Cessation
- 1996-11-12 AU AU77279/96A patent/AU703409B2/en not_active Ceased
- 1996-11-12 CZ CZ981501A patent/CZ150198A3/cs unknown
- 1996-11-12 HU HU9903459A patent/HUP9903459A3/hu unknown
- 1996-11-13 CO CO96059738A patent/CO4770955A1/es unknown
- 1996-11-13 PE PE1996000813A patent/PE17798A1/es not_active Application Discontinuation
- 1996-11-14 ES ES96308216T patent/ES2258771T3/es not_active Expired - Lifetime
- 1996-11-14 DE DE69635886T patent/DE69635886T2/de not_active Expired - Lifetime
- 1996-11-14 EP EP96308216A patent/EP0774461B1/en not_active Expired - Lifetime
- 1996-11-14 AT AT96308216T patent/ATE319685T1/de not_active IP Right Cessation
- 1996-11-15 AR ARP960105204A patent/AR004602A1/es unknown
- 1996-11-15 YU YU60796A patent/YU60796A/sh unknown
- 1996-11-15 AR ARP960105205A patent/AR006748A1/es unknown
-
1998
- 1998-05-14 NO NO982202A patent/NO982202D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP9903459A2 (hu) | 2001-04-28 |
KR19990067598A (ko) | 1999-08-25 |
PE17798A1 (es) | 1998-04-18 |
CO4770955A1 (es) | 1999-04-30 |
HUP9903459A3 (en) | 2001-08-28 |
YU60796A (sh) | 1998-12-23 |
CA2237910C (en) | 2005-12-27 |
WO1997018199A1 (en) | 1997-05-22 |
EA001617B1 (ru) | 2001-06-25 |
EP0774461A1 (en) | 1997-05-21 |
EP0774461B1 (en) | 2006-03-08 |
AU703409B2 (en) | 1999-03-25 |
NO982202L (no) | 1998-05-14 |
BR9611511A (pt) | 1999-05-04 |
ES2258771T3 (es) | 2006-09-01 |
CZ150198A3 (cs) | 1998-10-14 |
AR004602A1 (es) | 1998-12-16 |
DE69635886D1 (de) | 2006-05-04 |
IL124487A0 (en) | 1998-12-06 |
AU7727996A (en) | 1997-06-05 |
ATE319685T1 (de) | 2006-03-15 |
AR006748A1 (es) | 1999-09-29 |
CA2237910A1 (en) | 1997-05-22 |
EA199800377A1 (ru) | 1998-10-29 |
NZ323205A (en) | 1999-06-29 |
TR199800877T2 (xx) | 1998-09-21 |
PL326695A1 (en) | 1998-10-26 |
DE69635886T2 (de) | 2006-10-19 |
IL124487A (en) | 2001-01-11 |
CN1202167A (zh) | 1998-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE211131T1 (de) | Arylsulfonylaminohydroxamsäurederivate | |
DK0696577T3 (da) | Syntetiske excitatoriske aminosyrer | |
DE69611361D1 (de) | Chinazolin-derivate | |
DE69522717D1 (de) | Chinazolinderivate | |
DE69610698D1 (de) | Chinazolin-derivate | |
ATE199150T1 (de) | Diphenylmethylenpiperidin-derivate | |
DE69635886D1 (de) | Exzitatorisch wirkende Aminosäurederivate | |
NO950477D0 (no) | Aminosyrederivater | |
BR9611509A (pt) | Antagonistas de receptores de aminoácidos excitativos | |
DE69606053D1 (de) | Modifizierte fluorsulfonsäure | |
DE69604999D1 (de) | Brückenverbinder | |
DE69601527D1 (de) | Pyrrolylbenzimidazol-Derivate | |
BR9610239A (pt) | Proteínas de fusão-alérgeno-xcd32 | |
ATA100695A (de) | Prothrombin-derivate | |
BR9609671A (pt) | Amino uracilas substituídas | |
ATE240307T1 (de) | Diarylalkenylamin-derivate | |
DE69627830D1 (de) | Pyrazol-derivate | |
DE59607054D1 (de) | 4-Amino-benzoylguanidin-Derivate | |
ATE177102T1 (de) | Chromanderivate | |
DE59610106D1 (de) | Fluorbenzylether-Derivate | |
DK0843675T3 (da) | Aza-anthracyclinonderivater | |
DE59607055D1 (de) | 4-Mercapto-benzoylguanidin-Derivate | |
DE69620514D1 (de) | 5-aminoflavon-derivate | |
SE9502505D0 (sv) | New amino acid derivatives | |
SE9503923D0 (sv) | New amino acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |